Studies have investigated the dysregulation of LINC-ROR in tumorigenesis by evaluating the increased LINC-ROR expression in numerous malignancies, including pancreatic, colon, lung, bladder, endometrial, breast, hepatocellular, nasopharyngeal cancers, and ESCC, as well as its heterogenic function in glioblastoma[15,26-28]. The gene discussed is LINC-ROR; the disease is glioblastoma.